Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Nexobrid Market Report 2025

Nexobrid Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Formulation (Topical Gel, Spray, Ointment), By Clinical Indication (Burn Care, Chronic Wound Care, Trauma Care), By Distribution Channel (Hospitals, Ambulatory Surgical Centers (ASCs), Retail Pharmacies, Online Pharmacies), By End-User (Adult, Pediatric, Geriatric)

Nexobrid Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Nexobrid Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Nexobrid Market Definition

Nexobrid is a topical enzymatic debridement agent designed to treat severe burns. It selectively removes eschar while preserving healthy tissue, accelerating wound healing, and minimizing the need for surgical procedures. This advanced formulation enhances recovery outcomes and offers a non-invasive solution for burn care. 

The main types of nexobrid formulations are topical gel, Spray, and ointment. A topical gel formulation is designed for direct skin application, promoting healing by delivering active ingredients efficiently to the affected area. It is applicable in several clinical indications, such as burn care, chronic wound care, and trauma care, and is distributed through various distribution channels, including hospitals, ambulatory surgical centers (ASCs), retail pharmacies, and online pharmacies, and is used by several end users, such as adults, pediatrics, and geriatrics.

Nexobrid Market Segmentation

The nexobrid market covered in this report is segmented –

1) By Formulation: Topical Gel; Spray; Ointment

2) By Clinical Indication: Burn Care; Chronic Wound Care; Trauma Care

3) By Distribution Channel: Hospitals; Ambulatory Surgical Centers (ASCs); Retail Pharmacies; Online Pharmacies

4) By End-User: Adult; Pediatric; Geriatric

Nexobrid Market Size and growth rate 2025 to 2029: Graph

Nexobrid Market Size 2025 And Growth Rate

The nexobrid market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the increasing prevalence of burn injuries, growing industrial activity and related accidents, increasing awareness of advanced burn treatment options, government funding for burn care treatment programs, and rising healthcare infrastructure in emerging economies.

Nexobrid Market Growth Forecast

The nexobrid market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the growing demand for faster and more effective burn healing solutions, increasing government initiatives for burn care, enhanced accessibility to advanced medical treatments, expansion of healthcare facilities in low- and middle-income countries, growing awareness of the benefits of enzymatic debridement. Major trends in the forecast period include growth in the adoption of advanced wound care products, rising preference for minimally invasive treatments, adoption of AI-driven technologies in burn treatment, integration of regenerative medicine in burn recovery, and collaborative partnerships between governments and healthcare providers.

Book your 30 minutes free consultation with our research experts

Contact Us

Nexobrid Market Driver: Rising Prevalence Of Burn Injuries To Drive The Market Growth

The increasing prevalence of burn injuries is expected to fuel the growth of the nexobrid market going forward. Burn injuries refer to physical damage to the skin or other tissues leading to tissue destruction, pain, and impaired function. Occupational hazards in industries such as construction, manufacturing, and healthcare increase burn injury risks due to exposure to open flames, hot surfaces, and hazardous chemicals. Nexobrid aids in burn recovery by efficiently removing eschar from burn wounds, accelerating healing, and minimizing the need for surgery, ultimately enhancing patient outcomes. For instance, in October 2023, according to a report published by the World Health Organization, a Switzerland-based intergovernmental organization, approximately 180,000 deaths occur annually due to burns, with the majority happening in low- and middle-income countries. Therefore, the increasing prevalence of burn injuries will drive the nexobrid market growth.

Global Nexobrid Market Major Players

Major companies operating in the nexobrid market are MediWound Ltd.

Global Nexobrid Market Trend: Enhancing Emergency Preparedness With Advanced Burn Care Treatments

The key trend in the nexobrid market is the development of advanced eschar removal drug products to meet the increasing demand for effective, non-invasive burn care solutions. Eschar removal drugs are designed to break down dead tissue (eschar) formed over burns or wounds, facilitating healing and preventing infections. These treatments support burn care by promoting tissue regeneration and potentially minimizing the need for surgical debridement. For instance, in December 2022, MediWound Ltd., an Israel-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved NexoBrid (anacaulase-bcdb) for the removal of eschar in adults with deep partial-thickness or full-thickness thermal burns. This innovative treatment features a unique proteolytic enzyme formulation that effectively removes burn eschar within four hours while preserving healthy tissue. As a non-surgical option for burn treatment, it offers a quick and efficient alternative for patients. NexoBrid is approved in over 43 countries, including the United States, and is also supported by the biomedical advanced research and development authority (BARDA) to enhance burn care and improve emergency preparedness efforts.

Nexobrid Market Merger And Acquisition: Bharat Serums And Vaccines Partners With MediWound To Expand Access To NexoBrid For Burn Care In India

In December 2022, Bharat Serums and Vaccines (BSV) Limited, an India-based biopharmaceutical company, partnered with MediWound Ltd. to enhance burn care in India by broadening access to NexoBrid, an advanced treatment for severe burns, with a special emphasis on supporting women and security personnel. Through this partnership, Bharat Serums and Vaccines aims to address critical gaps in burn management and improve patient outcomes nationwide. MediWound Ltd. is an Israel-based biopharmaceutical company that manufactures NexoBrid.

Regional Analysis For The Global Nexobrid Market

North America was the largest region in the nexobrid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nexobrid market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nexobrid market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Nexobrid Market?

The nexobrid market consists of sales of cream, liquid solution, and powder. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Nexobrid Industry?

The nexobrid market research report is one of a series of new reports from The Business Research Company that provides nexobrid market statistics, including the nexobrid industry global market size, regional shares, competitors with the nexobrid market share, detailed nexobrid market segments, market trends, and opportunities, and any further data you may need to thrive in the nexobrid industry. This nexobrid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Nexobrid Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The nexobrid market covered in this report is segmented –
1) By Formulation: Topical Gel; Spray; Ointment
2) By Clinical Indication: Burn Care; Chronic Wound Care; Trauma Care
3) By Distribution Channel: Hospitals; Ambulatory Surgical Centers (ASCs); Retail Pharmacies; Online Pharmacies
4) By End-User: Adult; Pediatric; Geriatric
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled MediWound Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Nexobrid Market Characteristics

    3. Nexobrid Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Nexobrid Market Trends And Strategies

    5. Nexobrid Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Nexobrid Growth Analysis And Strategic Analysis Framework

    6.1. Global Nexobrid PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Nexobrid Market Growth Rate Analysis

    6.4. Global Nexobrid Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Nexobrid Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Nexobrid Total Addressable Market (TAM)

    7. Global Nexobrid Pricing Analysis & Forecasts

    8. Nexobrid Market Segmentation

    8.1. Global Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Topical Gel

    Spray

    Ointment

    8.2. Global Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Burn Care

    Chronic Wound Care

    Trauma Care

    8.3. Global Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals

    Ambulatory Surgical Centers (ASCs)

    Retail Pharmacies

    Online Pharmacies

    8.4. Global Nexobrid Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Adult

    Pediatric

    Geriatric

    9. Global Nexobrid Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Nexobrid Market Regional And Country Analysis

    10.1. Global Nexobrid Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Nexobrid Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Nexobrid Market

    11.1. Asia-Pacific Nexobrid Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Nexobrid Market

    12.1. China Nexobrid Market Overview

    12.2. China Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Nexobrid Market

    13.1. India Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Nexobrid Market

    14.1. Japan Nexobrid Market Overview

    14.2. Japan Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Nexobrid Market

    15.1. Australia Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Nexobrid Market

    16.1. South Korea Nexobrid Market Overview

    16.2. South Korea Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Nexobrid Market

    17.1. Western Europe Nexobrid Market Overview

    17.2. Western Europe Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Nexobrid Market

    18.1. UK Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Nexobrid Market

    19.1. Germany Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Nexobrid Market

    20.1. France Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Nexobrid Market

    21.1. Eastern Europe Nexobrid Market Overview

    21.2. Eastern Europe Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Nexobrid Market

    22.1. North America Nexobrid Market Overview

    22.2. North America Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Nexobrid Market

    23.1. USA Nexobrid Market Overview

    23.2. USA Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Nexobrid Market

    24.1. Canada Nexobrid Market Overview

    24.2. Canada Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Nexobrid Market

    25.1. South America Nexobrid Market Overview

    25.2. South America Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Nexobrid Market

    26.1. Middle East Nexobrid Market Overview

    26.2. Middle East Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Nexobrid Market

    27.1. Africa Nexobrid Market Overview

    27.2. Africa Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Nexobrid Market Competitive Landscape And Company Profiles

    28.1. Nexobrid Market Competitive Landscape

    28.2. Nexobrid Market Company Profiles

    28.2.1. MediWound Ltd. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Nexobrid Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Nexobrid Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Nexobrid Market

    32. Recent Developments In The Nexobrid Market

    33. Nexobrid Market High Potential Countries, Segments and Strategies

    33.1 Nexobrid Market In 2029 - Countries Offering Most New Opportunities

    33.2 Nexobrid Market In 2029 - Segments Offering Most New Opportunities

    33.3 Nexobrid Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Nexobrid Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Nexobrid Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Global Nexobrid Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: Asia-Pacific, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: China, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: India, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Japan, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: Australia, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: South Korea, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: Western Europe, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: UK, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: Germany, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: France, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: Eastern Europe, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: North America, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: USA, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: Canada, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: South America, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Middle East, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Africa, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 60: MediWound Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Nexobrid Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Nexobrid Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Global Nexobrid Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: Asia-Pacific, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: China, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: India, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Japan, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: Australia, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: South Korea, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: Western Europe, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: UK, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: Germany, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: France, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: Eastern Europe, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: North America, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: USA, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: Canada, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: South America, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Middle East, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Nexobrid Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Nexobrid Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Africa, Nexobrid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 60: MediWound Ltd. Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

What Is The Pharmaceutical Processing Seals Market Overview In 2022?

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the high potency apis market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the covid-19 current therapy market research report 2022 with industry size, share, segments and market growth

Read More

Light Fidelity (Li-Fi)/Visible Light Communication Global Market Report 2025 – By Component (LED, Photodetectors, Microcontrollers (MCU) ), By Transmission Type (Unidirectional, Bidirectional ), By Application (Indoor Networking, LBS (Location Based Services), In-Flight Communication and Entertainment, Underwater Communication, Other Applications ), By Industry Vertical (Retail, Electronics, Defense and Security, Automotive and Transport, Aerospace and Aviation, Healthcare, Other Industry Verticals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Protein A Resin Global Market Report 2025 – By Type (Natural Protein A, Recombinant Protein A), By Matrix Type (Agarose-Based Protein A, Glass/Silica-Based Protein A, Organic Polymer-Based Protein A), By Application (Antibody Purification, Immunoprecipitation), By End User (Biopharmaceutical Manufacturers, Clinical Research Laboratories, Academic Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Ataxia Global Market Report 2025 – By Type (Friedreich's Ataxia, Ataxia-telangiectasia, Episodic Ataxia, Other Types), By Product (Treatment, Diagnosis), By Dosage Form (Solid, Liquids, Other Dosage Forms), By Route of Administration (Oral, Parenteral, Other Routes of Administration), By End User (Hospital, Clinics, Home Healthcare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Helicopter Engines Global Market Report 2025 – By Type (Piston Engine, Gas Turbine Engine, Stamping Engine), By Weight (Light, Medium, Heavy), By Point Of Sale (New, Pre-Owned), By Application (Emergency Medical Services, Corporate Services, Search And Rescue Operations, Oil And Gas, Defense, Homeland Security, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Panuveitis Treatment Global Market Report 2025 – By Drug Class (Anti-Inflammatory, Antimicrobial Drugs, Immunotherapy And Targeted Therapies), By Route of Administration (Oral, Topical), By End Users (Hospitals, Home Care, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Intrauterine Devices Global Market Report 2025 – By Product (Hormonal Intrauterine Device, Copper Intrauterine Device), By Age Group (15-24 Years, 25-34 Years, 35-44 Years, Above 44 Years), By End-User (Hospitals, Gynecology Clinics, Community Healthcare, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Tooth Filling Materials Global Market Report 2025 – By Product (Composite Resin, Silver Amalgam, Glass Ionomer, Gold Fillings, Other Products), By Filling (Direct, Indirect), By End Use (Hospitals, Dental Clinics, Other End Uses) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Extended Reality Display Global Market Report 2025 – By Display Type (Liquid Crystal Displays (LCD), Organic Light-Emitting Diode (OLED), Other Display Type), By Component (Hardware, Software, Services), By Solution (Business Engagement, Consumer Engagement), By Application (Augmented Reality, Mixed Reality, Virtual Reality), By End-User Industry (Gaming and Entertainment, Healthcare, Education, Military and Defense, Automotive and Manufacturing, Retail, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Nexobrid market?

Nexobrid is a topical enzymatic debridement agent designed to treat severe burns. It selectively removes eschar while preserving healthy tissue, accelerating wound healing, and minimizing the need for surgical procedures. This advanced formulation enhances recovery outcomes and offers a non-invasive solution for burn care. For further insights on the Nexobrid market, request a sample here

How will the Nexobrid market drivers and restraints affect the market dynamics? What forces will shape the Nexobrid industry going forward?

The Nexobrid market major growth driver - Rising Prevalence Of Burn Injuries To Drive The Market Growth. For further insights on the Nexobrid market, request a sample here

What is the forecast market size or the forecast market value of the Nexobrid market?

The Nexobrid market size has grown strongly in recent years. The nexobrid market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the increasing prevalence of burn injuries, growing industrial activity and related accidents, increasing awareness of advanced burn treatment options, government funding for burn care treatment programs, and rising healthcare infrastructure in emerging economies. The nexobrid market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the growing demand for faster and more effective burn healing solutions, increasing government initiatives for burn care, enhanced accessibility to advanced medical treatments, expansion of healthcare facilities in low- and middle-income countries, growing awareness of the benefits of enzymatic debridement. Major trends in the forecast period include growth in the adoption of advanced wound care products, rising preference for minimally invasive treatments, adoption of AI-driven technologies in burn treatment, integration of regenerative medicine in burn recovery, and collaborative partnerships between governments and healthcare providers. For further insights on the Nexobrid market, request a sample here

How is the Nexobrid market segmented?

The nexobrid market covered in this report is segmented –
1) By Formulation: Topical Gel; Spray; Ointment
2) By Clinical Indication: Burn Care; Chronic Wound Care; Trauma Care
3) By Distribution Channel: Hospitals; Ambulatory Surgical Centers (ASCs); Retail Pharmacies; Online Pharmacies
4) By End-User: Adult; Pediatric; Geriatric For further insights on the Nexobrid market, request a sample here

Which region has the largest share of the Nexobrid market? What are the other regions covered in the report?

North America was the largest region in the nexobrid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nexobrid market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Nexobrid market, request a sample here.

Who are the major players in the Nexobrid market?

Major companies operating in the nexobrid market are MediWound Ltd. . For further insights on the Nexobrid market, request a sample here.

What are the key trends in the Nexobrid market?

Major trends in the Nexobrid market include Enhancing Emergency Preparedness With Advanced Burn Care Treatments. For further insights on the Nexobrid market, request a sample here.

What are the major opportunities in the Nexobrid market? What are the strategies for the Nexobrid market?

For detailed insights on the major opportunities and strategies in the Nexobrid market, request a sample here.

How does the Nexobrid market relate to the overall economy and other similar markets?

For detailed insights on Nexobrid's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Nexobrid industry?

For detailed insights on the mergers and acquisitions in the Nexobrid industry, request a sample here.

What are the key dynamics influencing the Nexobrid market growth? SWOT analysis of the Nexobrid market.

For detailed insights on the key dynamics influencing the Nexobrid market growth and SWOT analysis of the Nexobrid industry, request a sample here.